Completed Clinical Trials

Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma

By April 24, 2017 No Comments


Malignant (Pleural) Mesothelioma

Estimated Enrollment: 10

Age Group: Child, Adult, Senior

Gender: All

Study Type: Interventional

Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: NL24050.000.08

Study First Received: June 1, 2010

Last Updated: February 26, 2014

Estimated Primary Completion Date: October 2011


Primary Outcome Measures:

number of cytotoxic T cells and regulatory T cells in the blood of patients|safety and toxicity

Sponsors and Collaborators:

Erasmus Medical Center

Website Link:

Leave a Reply

Call Now ButtonCall Now